Gilead CEO Milligan capped a rocky year — and his career — with the new #1 compensation package in the big leagues of biopharma
Gilead’s recently departed CEO John Milligan capped a year marked by setbacks, a major write-off and big questions about the company’s future under a new helmsman with what currently stands as the biggest pay package of all the major league CEOs in biopharma.
Image: John Milligan speaks to Bloomberg in 2014 Bloomberg
Basic subscription required
Unlock this story instantly and join 54,900+ biopharma pros reading Endpoints daily — and it's free.